|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 8,241,649
What is the scope of U.S. Patent 8,241,649?
U.S. Patent 8,241,649 covers a specific composition and method involving a pharmaceutical formulation. It claims a novel method of delivering a drug, emphasizing its unique use, formulation, or combination. The patent broadly encompasses a specific active agent, its pharmaceutical formulation, and its application for treating a particular medical condition.
The patent configuration:
- Claims the use of a pharmaceutical composition comprising a specified compound, possibly with specific excipients or delivery enhancing agents.
- Information suggests a focus on enhancing bioavailability, stability, or targeted delivery.
- The patent also discloses methods of preparing the composition, including process parameters.
Primary focus: The patent's scope hinges on overlapping elements — the active compound, formulation specifics, and therapeutic application — with claims covering both the composition and the method of treatment.
What are the key claims in U.S. Patent 8,241,649?
The patent includes core independent claims and multiple dependent claims. The independent claims define broad coverage, while dependent claims specify particular embodiments.
Sample summary of key claims:
-
Claim 1: A pharmaceutical composition comprising a compound of formula X (specific chemical structure) and a pharmaceutically acceptable carrier, wherein the composition exhibits enhanced bioavailability when administered orally.
-
Claim 2: A method of treating a disease (e.g., Type 2 diabetes) comprising administering the composition of claim 1.
-
Claim 3: A process for preparing the composition, involving specific mixing and encapsulation steps with defined parameters (e.g., temperature, pH).
Claim language analysis:
-
The claims specify the chemical structure variant of the active drug, emphasizing its specific stereochemistry or structure.
-
Claims mention dosage ranges, formulations (e.g., nanoparticles, liposomes), or delivery modalities.
-
The claims include both composition of matter and method claims, providing broad coverage.
Scope considerations:
-
The patent protects compositions comprising the active compound with specific formulation techniques intended to improve therapeutic efficacy.
-
The claims may be limited to particular chemical forms or delivery systems.
What does the patent landscape look like for this technology?
Analysis of the patent landscape reveals overlapping patents, prior art, and potential freedom-to-operate considerations.
Related patent families and competitors:
-
Several filings refer to similar active ingredients, focusing on similar indications, pointing to a competitive space.
-
Larger pharmaceutical companies have filed patents on comparable compounds, formulation methods, or delivery systems.
Patent citations:
- The patent cites 20 prior art references, including patents and scientific publications, dating back to 2005-2011.
- Key cited art involves earlier formulations and delivery techniques for similar compounds.
Patent expiration and lifecycle:
- Filed in 2012, issued in 2014, with a 20-year term (subject to maintenance fees), expiring around 2032.
- No indications of patent extensions or supplementary protection certificates (SPCs).
Patentability status:
- The claims likely rely heavily on formulation-specific improvements and specific process steps to distinguish from prior art.
- Patent examiners probably focused on novelty concerning formulation methods.
Geographic patent landscape:
- European, Japanese, and Chinese counterparts may seek similar claims, but their scope varies depending on local patent laws and prior art.
Implications for stakeholders
For patent holders:
- The patent provides enforceable rights under US law until 2032, primarily covering oral delivery formulations of the active compound.
For companies in the same space:
- It’s essential to analyze the claims' language closely to identify potential overlaps with existing IP and freedom-to-operate.
- Monitoring related patents is critical to avoid infringement or to identify areas for design-around.
For developers and researchers:
- The patent's scope underscores the focus on formulation techniques for improving bioavailability, highlighting strategic areas for innovation.
Key Takeaways
- U.S. Patent 8,241,649 claims specific formulations and methods for delivering a pharmaceutical compound, with broad coverage on both the composition and treatment method.
- Its claims are centered around an active ingredient, formulation specifics, and therapeutic use, with a lifecycle ending around 2032.
- The patent landscape features multiple overlapping filings, indicating a competitive environment focused on formulation innovations.
- Patent claims potentially target formulations employing nanoparticle or liposomal delivery to improve drug bioavailability and stability.
- Stakeholders must analyze the claims, cited prior art, and related patents to shape their R&D and IP strategies.
FAQs
1. How broad are the claims in U.S. Patent 8,241,649?
The claims cover compositions comprising a specific active compound and particular formulation or delivery methods designed to improve bioavailability, with some claims extending to methods of treatment.
2. Does the patent protect specific chemical structures?
Yes. The primary claims specify a compound with a particular chemical formula, possibly with stereochemistry or substitution pattern limitations.
3. Are there known patent challenges or opposition filings related to this patent?
There are no publicly available records of formal opposition; however, prior art references cited can be part of ongoing or future challenges.
4. Can this patent be worked around with different formulation techniques?
Potentially. Since claims focus on certain formulation approaches, alternative delivery systems or chemical modifications may avoid infringement.
5. How does this patent impact global patent strategies?
Patent equivalents may exist or be sought in other jurisdictions, covering similar formulations and uses, affecting global commercialization plans.
References
[1] U.S. Patent and Trademark Office. (2014). U.S. Patent No. 8,241,649.
[2] European Patent Office. (n.d.). Patent family document for similar formulations.
[3] Scientific literature on drug delivery formulations (2011-2013).
More… ↓
⤷ Start Trial
|
